{
    "title": "Immunovant shares surge as early antibody treatment data beats expectations",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12562495/Immunovant-shares-surge-early-antibody-treatment-data-beats-expectations.html",
    "date": "2023-09-26",
    "keywords": [
        "drug",
        "antibody",
        "treatment",
        "imvt1402",
        "analyst",
        "disease",
        "bhanvi",
        "satija",
        "immunovant",
        "data",
        "class",
        "study",
        "tuesday",
        "earlystage",
        "developer",
        "year",
        "market",
        "capitalization",
        "injection",
        "homerun",
        "scenario",
        "jp",
        "brian",
        "cheng",
        "autoimmune",
        "tail",
        "region",
        "help",
        "immune",
        "system",
        "johnson",
        "ucb",
        "development",
        "rival",
        "drugmaker",
        "vyvgart",
        "hytrulo",
        "igg",
        "immunoglobulin",
        "inflammation",
        "part",
        "november",
        "potential",
        "takeout",
        "yaron",
        "plasma",
        "protein",
        "blood",
        "serum",
        "albumin",
        "shareholder",
        "stake",
        "lseg",
        "roivant",
        "candidate",
        "bowel",
        "dennis",
        "price",
        "book",
        "value",
        "benchmark",
        "reporting",
        "bengaluru",
        "editing",
        "krishna",
        "chandra",
        "eluri",
        "shounak",
        "dasgupta"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}